PERKINELMER INC. COMMON STOCK

NetDania - New 12 months Low: PerkinElmer, Inc.

13 Oct 2022 09:45:13 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

27 Sep 2022 10:15:54 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

23 Sep 2022 09:45:13 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

22 Sep 2022 09:45:06 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

21 Sep 2022 15:46:21 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

20 Sep 2022 10:15:01 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

19 Sep 2022 10:08:43 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

16 Sep 2022 09:45:26 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

07 Sep 2022 10:08:35 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

14 Jul 2022 09:54:24 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

17 Jun 2022 16:05:03 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

16 Jun 2022 11:08:17 By NetDania Notify

NetDania - New 12 months Low: PerkinElmer, Inc.

13 Jun 2022 09:45:11 By NetDania Notify

Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study to Investigate the T Cell Response to SARS-CoV-2 Infection

18 May 2021 09:15:00 By Nasdaq GlobeNewswire

Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency

11 May 2021 09:15:00 By Nasdaq GlobeNewswire

Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups

29 Apr 2021 09:15:00 By Nasdaq GlobeNewswire

Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses

27 Apr 2021 09:15:00 By Nasdaq GlobeNewswire